Simply Wall St.
Looking at the Narrative for OptimizeRx After Guidance Boost and Recurring Revenue Shift
📊
AI Sentiment
Positive
7/10
- Home
- OPRX
as of 12-10-2025 3:45pm EST
$14.03
+$0.12
+0.86%
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
Chart Type:
Time Range:
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 272.0M | IPO Year: | N/A |
| Target Price: | $14.83 | AVG Volume (30 days): | 207.4K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.00 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.99 - $22.25 | Next Earning Date: | 11-06-2025 |
| Revenue: | $109,506,000 | Revenue Growth: | 24.18% |
| Revenue Growth (this year): | 19.77% | Revenue Growth (next year): | 11.33% |
AI-Powered OPRX Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 75.00%
75.00%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of OptimizeRx Corporation (OPRX)
Silvestro Stephen L
Sell
Chief Executive Officer
OPRX Oct 3, 2025
Avg Cost/Share
$18.75
Shares
1,620
Total Value
$30,375.00
Owned After
188,916
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Silvestro Stephen L | OPRX | Chief Executive Officer | Oct 3, 2025 | Sell | $18.75 | 1,620 | $30,375.00 | 188,916 |
Latest OptimizeRx Corporation News
OPRX Breaking Stock News: Dive into OPRX Ticker-Specific Updates for Smart Investing
Compare OPRX vs Leading Stocks
See how OPRX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "OPRX OptimizeRx Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.